We reviewed randomized controlled trials of complementary and alternative medicine (CAM) treatments for depression, anxiety, and sleep disturbance in nondemented older adults.
exceeding a prevalence of 60% in a nationally representative survey conducted by the National Center for Health Statistics in 2002. 1 Often labeled as complementary and alternative medicine (CAM), these practices encompass a diverse range of therapies and techniques but have in common a general lack of acceptance and/or use in traditional medical settings. The historical lack of rigorous scientific study of CAM significantly impedes its incorporation into mainstream medicine. Nonetheless, the public health issues raised by its increasing use and the desire to identify its potentially valid therapeutic elements have spurred interest in CAM-related research.
Although national surveys indicate that CAM use is greater in younger than in older age groups, 2 many elderly people also use CAM therapies. [3] [4] [5] Older adults in particular often use spiritual health practices (e.g., prayer) and vitamin supplements. 1, 6 Yet, even excluding prayer and megavitamins, Barnes and colleagues 1 found that 33% of U.S. adults in their sixties had used CAM within the preceding year. Other studies have identified ethnic and geographic subpopulations of older adults that may use CAM even more frequently. 7, 8 Cohort effects also likely influence differences in CAM use, such that aging baby boomers may continue to incorporate CAM into their healthcare practices.
CAM use in older adults presents several important and unique issues. CAM therapies are usually tried T J Clin Psychiatry 68:10, October 2007 concurrently with conventional medical treatments, although often without the knowledge of conventional practitioners. 5, 9 In 2000, 6% of older Americans were taking both an herbal remedy and a prescription drug. 5 Because older Americans frequently take multiple prescription drugs, and given evidence that some CAM treatments can adversely interact with prescription medications, 10, 11 CAM use among older adults may pose important safety risks. 12 Additionally, age-related differences in health beliefs and declining cognitive abilities could influence the effects of CAM mind-body interventions on older adults. Despite recent increases in CAM research, studies with older adults are still relatively scarce.
The motivations for CAM use are varied and multidetermined. Both younger and older individuals often cite chronic pain and psychological distress (including insomnia, depression, and anxiety) as reasons for using CAM. 2, 13 Unfortunately, depressive and anxiety symptoms affect large numbers of older adults-as many as half of institutionalized elderly persons. 14, 15 Likewise, nearly half of older adults report sleep difficulties. 16 Some older adults, who view mental illnesses and psychotropic medications as stigmatizing, may be more receptive to CAM therapies because they prefer "natural" treatments that can be self-initiated without divulging embarrassing symptoms.
CAM treatments for dementia-related symptoms in older adults have been previously reviewed, 17 as have CAM therapies for anxiety and depression among general adult populations. 18, 19 We could not find any review of CAM for psychological symptoms in nondemented older adults. Notably, 85% or more of older adults are cognitively intact, 20 and their use of CAM to treat psychological symptoms is likely to increase. We reviewed randomized controlled trials (RCTs) of CAM treatments for cognitively intact older adults with depression, anxiety, and/or sleep disturbance. We limited the review to studies of at least moderate sample size and trial duration, systematically assessed each study's quality, and sought to identify study characteristics associated with positive versus negative outcomes.
METHOD Data Sources
We searched PubMed (1966 ( -September 2006 and PsycINFO (1984 -September 2006 21 Additional articles for consideration were identified via manual review of the references in articles retrieved from the database searches.
Study Selection
This review included RCTs that met the following criteria: (1) prospective design ≥ 2 weeks in duration; (2) mean participant age ≥ 60 years; (3) sample size ≥ 30 (approximate median sample size of studies identified); (4) at least 1 primary outcome measure assessing mood, depression, anxiety, sleep, or some combination of these; (5) no primary diagnosis of dementia or cognitive disorder among participants; (6) availability in English; and (7) inclusion of participants other than "healthy" or "normal" adults (i.e., not prevention trials). Six RCTs of CAM treatments among asymptomatic, healthy older adults that assessed changes in mood, anxiety, and sleep were excluded. [22] [23] [24] [25] [26] [27] Although not necessarily described or designed as such, these appeared to be more prevention than treatment trials; notably, all 6 had negative results.
While cognitive disorders and their associated neuropsychiatric symptoms are prevalent among older adults, we deemed the efficacy of CAM in this group to be a different issue beyond the scope of this review. We also did not include studies testing cognitive-behavioral therapy (CBT), including those that incorporated relaxation techniques as a component of CBT, or studies of repetitive transcranial magnetic stimulation (rTMS). Although CBT and rTMS are sometimes listed among CAM treatments, we believed these treatments are sufficiently evidencebased and accepted in conventional medical settings to be excluded from this review.
Data Extraction
The heterogeneity of study outcomes, populations sampled, and therapies implemented precluded combining data for meta-analysis. In order to evaluate the methodology of the individual studies, we adopted a modified version of the newly developed Scale for Assessing Scientific Quality of Investigations (SASQI) ( Table 1 ). This 19-item scale (score range, 0-20) was derived from an article by Jeste et al. 28 Several items were adapted or added for this review, based on expert suggestions for improving the quality of CAM research. 29, 30 For example, the difficulties in CAM research of masking group assignment and employing appropriate control conditions prompted expanded items to differentiate studies on these methodological issues. Other new items evaluated studies according to treatment standardization, assessments of treatment credibility, and reporting of adverse effects.
We categorized CAM therapies based on NCCAM's organizational scheme, 31 recognizing that these categories are imperfect and overlapping. For instance, traditional Chinese medicine is considered an "alternative medical system," but incorporates aspects of biological therapies (herbs), energy medicine (external qigong), mind-body medicine (Tai Chi), and body-based treatments (acupressure). Nonetheless, these categories help organize this complex array of treatment modalities into groups that share putative therapeutic elements and common methodological challenges.
The first author (T.W.M.) independently rated all 33 studies using the SASQI. Ten articles were randomly selected via computer-generated numbers for evaluation on the SASQI by a second author (J.L.W.), who was blinded to the first author's ratings. We rated studies as "positive" if the study authors reported that the experimental CAM intervention yielded significantly (p < .05) better outcomes than the control group (or outcomes statistically equivalent to an evidence-based active control) on at least 1 primary outcome measure related to sleep, depression, or anxiety.
Data Analysis
Interrater reliability for the 10 SASQI scores rated by 2 authors was determined by calculating the intraclass correlation, which was 0.94.
RESULTS
We identified 885 studies via database searches, of which 29 met our inclusion criteria. Additionally, 4 eligible studies were identified from manual bibliography searches, yielding a total of 33 studies for review ( Table 2) . Numerous studies related to CAM and Rationale for treatment protocol given; standardization of magnetic strength and questionnaire, interpractitioner reliability; asserted subjects blinded to treatment but not well described; sleep log, actigraphy duration and frequency of treatment sessions not well described; comprehensive inclusion/ exclusion criteria but methods for making diagnoses not described; unclear age was equivalent among groups and age was a predictor of outcome measures in regression analysis HADS, VSH Positive: massage > ATM and 8 Therapist training and standardization of treatments insufficiently described; some baseline TAU for depression; ATM differences between groups (failed randomization); control group inadequate; negative for and massage combined > aromatherapy component of treatment (ie, added nothing to massage) TAU for sleep PSQI Positive: AP > both controls 12 Not clear sham acupressure subjects adequately blinded; inadequate detail on blinding of outcome assessments; subjects matched at randomization on use of naps, exercise, and hypnotics; good assessments of treatment standardization psychological symptoms in older adults were identified that did not meet inclusion criteria, with the most common reasons being lack of prospective randomized controlled design, inadequate sample size, and inclusion of participants with known cognitive impairments.
The studies included had several limitations that merit mention and restrict what conclusions can be drawn about these treatments. Sample sizes remained generally small enough to engender significant risks of type II errors. This may be especially true of studies that enrolled less symptomatic participants. Very few studies used systematic psychiatric diagnoses, and many even failed to specify symptom thresholds for inclusion. Dropouts were generally poorly accounted for, and few studies implemented intent-to-treat data analysis. Many studies failed to provide enough details about inclusion/exclusion criteria and/or treatment protocols to allow for reliable replication. Despite the frequent assertion that CAM interventions are superior to conventional treatments in tolerability, assessments of adherence and side effects were overall poor. Additionally, while financial conflicts of interest are increasingly contentious in conventional medical studies, this was seldom addressed in the studies reviewed (only 5 studies explicitly addressed this), although this could be equally problematic in CAM research. Lastly, control conditions had significant limitations, including several trials with wait-list or treatment as usual groups. Controlling for additional time and attention given to subjects in active treatment as well as for participant expectations when receiving a concrete treatment (e.g., by using a support group or mock intervention) helps substantially to separate the therapeutic effects of the experimental treatment from these other nonspecific factors.
The mean SASQI score of the studies was 10.3 (SD = 3.5). The studies ranged in sample size from 30 to 202 (mean = 67), in duration from 2 to 52 weeks (mean = 8.5), and in average participant age from 61 to 82 years (mean = 70.5 years). Only one third of the studies were conducted in the United States, with the rest coming from Europe (24%), Asia (33%), or elsewhere (9%). The most common CAM treatments studied were mindbody interventions (36.4%), followed by biologicallybased (27.3%), energy-based (27.3%), and body-based/ manipulative treatments (9.1%). Many of the studies examined more than 1 type of symptom domain (e.g., depression and anxiety). The proportions of trials targeting specific symptoms were as follows: depression alone, 33.3% (11/33); anxiety alone, 3.0% (1/33); sleep disturbance alone, 45.5% (15/33); depression and anxiety, 15.2% (5/33); and depression, anxiety, and sleep disturbance, 3.0% (1/33).
Twenty-two (67%) of the studies were rated as positive. Comparisons of the positive and negative studies are summarized in Table 3 ; statistical comparisons were not computed due to the small number of studies and lack of power to detect differences. The mean SASQI for negative studies was notably higher than that for positive studies. Also of interest, 91% (10/11) of Asian studies were positive, compared to 55% (12/22) of studies from other regions. Studies primarily targeting sleep disturbances were positive in 77% (13/17) of cases, while 59% (10/17) of those targeting depression and/or anxiety were positive. The prevalence of positive studies according to CAM type varied considerably: mind-body (83%, 10/12), biologically-based (44%, 4/9), energy-based (56%, 5/9), and body-based/manipulative (100%, 3/3). Negative studies tended to have slightly higher sample sizes and treatment durations than positive studies, but their mean participant age was very similar to that of positive studies.
DISCUSSION
To our knowledge, this is the first systematic review of randomized controlled trials employing CAM for symptoms of depression, anxiety, and sleep disturbance among older adults without dementia. Of the 33 RCTs reviewed, two thirds were positive. The average SASQI score for included studies indicated generally modest methodological quality, as has historically been true in CAM research. Yet, the studies reviewed, by virtue of being RCTs and having sample sizes of 30 or more, were informative and worthy of examination. Strengths of this review include the use of a quantitative assessment of study quality, the inclusion of only randomized controlled studies, and an exploration of study attributes that were associated with positive versus negative treatment outcomes. Nonetheless, our review methodology had several limitations. Although we attempted to be exhaustive in our literature search, the volume of search results and long list of possible CAM therapies both increased the likelihood that we overlooked a publication that would have met entry criteria. Reviewing non-English publications was not feasible, but not doing so may have omitted certain studies. The definition of CAM is dynamic and subject to debate, necessitating a subjective judgment regarding the inclusion or exclusion of treatments in this broad category. Although we did not include studies that clearly enrolled persons with dementia, not all of the studies systematically excluded cognitively impaired participants. The reliability and validity of the SASQI has not been empirically evaluated, and SASQI ratings for this review cannot be considered completely impartial. Evaluating methodology and outcomes from such a diverse array of therapies makes comparisons less reliable and precludes meta-analysis, but we attempted to use SASQI items that could generalize across all CAM trials.
In spite of these methodological limitations, some general observations are possible. The higher methodological quality of negative studies was an interesting finding. This does not dismiss all positive results, however, as indeed some rigorously conducted studies yielded promising results for certain CAM therapies. Nonetheless, it draws attention to the need for careful assessment of study design before accepting the reported results. The high rate of positive studies from Asia could result from several factors: a lower SASQI score compared to American and European studies (8.7 vs. 11.1), stronger cultural expectations for CAM benefits in Asian researchers and participants, the type of CAM studied in Asia (i.e., relatively few biologically-based therapies), or better implementation of CAM therapies in cultures in which these originated.
Mind-body interventions proved effective in 10 out of 12 studies reviewed. As in younger adults, 65 these therapies appear to have promise for alleviating late-life insomnia. The Tai Chi study for sleep disturbance by Li et al. 42 was among the best in methodological quality and yielded notably positive results. A recent review of 26 controlled trials in general adult samples described relaxation therapies as generally effective for anxiety 19 ; however, none of the mind-body studies we reviewed focused primarily on anxiety disorders among older adults. Mindbody studies assessing depressive symptoms were often hampered by inadequate methodology, including unclear symptom thresholds and diagnostic inclusion criteria. All 3 studies of music therapy were positive, but all had inadequate control conditions.
Controlled trials of biologically-based CAM treatments (e.g., herbs, supplements) for mental disorders are not abundant, but they are especially scarce among older adults. For instance, there is at least modest evidence for the efficacy of treatments such as St. John's wort, s-adenosylmethionine (SAM-e), and omega-3 fatty acids for depression in younger adults. [66] [67] [68] However, only one similar trial was found in older adults, a positive German study of moderate methodological quality using St. John's wort for depression. 50 The most common biological therapy reviewed was melatonin for sleep disturbance, which yielded inconsistent results. Overall, less than half of biologically-based treatment trials were positive.
Eastern treatments based on energy manipulation, such as external qigong therapy, are particularly removed from mainstream Western medicine. Although 2 studies of external qigong in this review reported positive effects on depressed mood in older adults with pain, 53, 54 both studies had a SASQI score below the review's mean. Acupuncture is likewise based on concepts of manipulating bodily energy (qi) and has gained increasing acceptance for uses such as pain and nausea control. 69 A meta-analysis of 5 RCTs of acupuncture for depression in general adult samples revealed acupuncture to be equivalent to antidepressants, though caution was noted about insufficient methodology. 70 From our review, one RCT using acupuncture in older adults with stroke was negative for improving mood among minimally symptomatic participants, while another was positive for depression but fraught with methodological limitations. Another energy treatment some may no longer consider "alternative" is the use of visible light waves for treatment of circadian sleep disturbances and seasonal affective disorder. 71, 72 Light therapy appeared ineffective, however, in 2 trials for late-life depression. 57, 58 The final category of CAM treatments, body-based/ manipulative, had only 3 studies-all positive. Chiropractic care, a commonly employed manipulative therapy, has received little attention for mental disorders. However, massage, including acupressure massage, has been tried for psychological symptoms, especially among older or medically ill populations. All 3 trials of massage were positive (for a mixture of depression, sleep, anxiety symptoms); more rigorous studies are needed, but the acupressure trials were promising and above average in methodological quality (relative to other trials in this review).
Further study of CAM therapies among older adults with psychological symptoms is warranted but would benefit from improved methodology. CAM trials are challenging because of theoretical differences with evidence-based Western medicine, emphasis on treatment individualization and wellness, and difficulty choosing appropriate control groups. Factors related to aging, such as concomitant medications and illnesses as well as cognitive decline, also introduce some challenging confounds. Nonetheless, implementation of the criteria outlined in the SASQI-CAM (Table 1) would serve as a useful starting point. Additional considerations include (1) examination of mediating variables such as cognition and health beliefs, (2) use of flexible yet reproducible protocols (e.g., "toolbox approaches") when treatment individualization is a core component of the CAM therapy, (3) use of systematic psychiatric diagnoses and clear symptom thresholds in inclusion criteria, and (4) clear delineation of financial support and possible conflicts of interest.
CONCLUSIONS
Several factors argue for further study of CAM, including its widespread popularity, the potential for tapping unrealized therapeutic resources, the inability of current conventional treatments to substantially improve quality of life in many chronic illnesses, and the need for culturally competent medical care. Some CAM advocates may feel that imposing Western standards of evaluation on CAM is unnecessary, inappropriate, or culturally biased. We feel that systematic research with innovative methodologies created by both conventional and CAM researchers is crucial to reaping any widespread benefits that CAM therapies may offer and to preventing harm or deception that may come from well-intentioned or purely opportunistic CAM practices. Studies of CAM among older adults with mental disorders will be particularly important. U.S. demographic patterns are changing, and cohorts with high rates of CAM use are growing older. The number of older adults with mental illnesses is also increasing exponentially, 73 and depression, anxiety, and insomnia are likely to remain among the most prominent reasons that older adults use CAM.
Drug names: doxepin (Sinequan and others), fluoxetine (Prozac and others).
